ID

23158

Description

Responsible Party: Dimitris Repantis, Dr. med., Charite University, Berlin, Germany ClinicalTrials.gov Identifier: NCT02071615 History of Changes Other Study ID Numbers: 2012-003882-17 DRKS00005219 ( Registry Identifier: Deutsche Register Klinischer Studien (DRKS) ) Study First Received: February 15, 2014 Last Updated: April 16, 2014 Effects of Modafinil, Caffeine and Methylphenidate in Healthy Volunteers (MKM) ODM derived from: https://clinicaltrials.gov/ct2/show/NCT02071615

Lien

https://clinicaltrials.gov/ct2/show/NCT02071615

Mots-clés

Versions (1)
  1. 26-06-17 26-06-17 -
Téléchargé le

26 juni 2017

DOI

Pour une demande vous connecter.

Licence

Creative Commons BY 4.0
Modèle Commentaires :

Ici, vous pouvez faire des commentaires sur le modèle. À partir des bulles de texte, vous pouvez laisser des commentaires spécifiques sur les groupes Item et les Item.

Retour au modèle Commentaires
Groupe Item commentaires pour :

Item commentaires pour :

Vous devez être connecté pour pouvoir télécharger des formulaires. Veuillez vous connecter ou s’inscrire gratuitement.

Eligibility Modafinil, Caffeine and Methylphenidatein Healthy Volunteers DRKS00005219 NCT02071615 DRKS00005219

Anglais

Eligibility Modafinil, Caffeine and Methylphenidatein Healthy Volunteers NCT02071615 DRKS00005219

1 Formulaires  
Inclusion Criteria
Description

Inclusion Criteria

Alias
UMLS CUI-1
C1512693
Men
Description

Gender

Type de données

boolean

Alias
UMLS CUI [1]
C0079399
18 - 35 years
Description

Age

Type de données

boolean

Alias
UMLS CUI [1]
C0001779
Written consent (according to Arzneimittelgesetz (AMG) § 40 (1) 3b)
Description

Informed Consent

Type de données

boolean

Alias
UMLS CUI [1]
C0021430
Good knowledge of German
Description

Language Ability

Type de données

boolean

Alias
UMLS CUI [1]
C1145677
Right-handedness
Description

Handedness

Type de données

boolean

Alias
UMLS CUI [1]
C0023114
Healthy Volunteers
Description

Control Group

Type de données

boolean

Alias
UMLS CUI [1]
C0009932
Exclusion Criteria
Description

Exclusion Criteria

Alias
UMLS CUI-1
C0680251
Known hypersensitivity to the study medication
Description

Hypersensitivity to study medication

Type de données

boolean

Alias
UMLS CUI [1,1]
C0020517
UMLS CUI [1,2]
C0304229
All contraindications to the study medication: arrhythmia, hyperthyroidism , glaucoma , pheochromocytoma , congestive heart failure , diabetes mellitus, known liver and kidney dysfunction, vascular disease , angina, haemodynamically significant congenital heart disease , cardiomyopathy , myocardial infarction, channelopathies, arterial hypertension , cerebrovascular diseases , such as cerebral aneurysm , vascular abnormalities , including vasculitis and stroke.
Description

Contraindications to study medication

Type de données

boolean

Alias
UMLS CUI [1,1]
C1301624
UMLS CUI [1,2]
C0304229
Participation in other clinical trials during or within one month prior to this clinical trial
Description

Study Participation Status

Type de données

boolean

Alias
UMLS CUI [1]
C2348568
Medical or psychological circumstances that may endanger the proper conduct of the trial
Description

Hazard to Study Protocol

Type de données

boolean

Alias
UMLS CUI [1,1]
C0598697
UMLS CUI [1,2]
C2348563
Existing serious somatic diseases, even if they are not covered by the contraindications according to product information
Description

Comorbidity

Type de données

boolean

Alias
UMLS CUI [1]
C0009488
Existing psychiatric disorders and psychiatric disorders in prehistory
Description

Mental Disorder

Type de données

boolean

Alias
UMLS CUI [1]
C0004936
Smoker or ex-smoker for less than 5 years
Description

Smoking Status

Type de données

boolean

Alias
UMLS CUI [1]
C1519386
Regular caffeine consumption > 4 cups per day
Description

Caffeine consumption

Type de données

boolean

Alias
UMLS CUI [1]
C0948365
Subjects with irregular day -night rhythm (eg shift workers )
Description

Day/night cycles

Type de données

boolean

Alias
UMLS CUI [1]
C2371703
Unwillingness to the storage and disclosure of pseudonymous data as part of the clinical trial
Description

Unwilling

Type de données

boolean

Alias
UMLS CUI [1]
C0558080
Accommodation in an institution by court or administrative order (according to AMG § 40 (1) 4 )
Description

Accommodation

Type de données

boolean

Alias
UMLS CUI [1]
C0595920
MRI contraindications ( eg pacemakers , metallic or electronic implants , metallic splinters , tinnitus, surgical clips )
Description

MRI contraindications

Type de données

boolean

Alias
UMLS CUI [1,1]
C0024485
UMLS CUI [1,2]
C1301624
Retour au début de la page

Similar models

Eligibility Modafinil, Caffeine and Methylphenidatein Healthy Volunteers NCT02071615 DRKS00005219

1 Formulaires
Name
Type
Description | Question | Decode (Coded Value)
Type de données
Alias
Item Group
Inclusion Criteria
C1512693 (UMLS CUI-1)
Gender
Item
Men
boolean
C0079399 (UMLS CUI [1])
Age
Item
18 - 35 years
boolean
C0001779 (UMLS CUI [1])
Informed Consent
Item
Written consent (according to Arzneimittelgesetz (AMG) § 40 (1) 3b)
boolean
C0021430 (UMLS CUI [1])
Language Ability
Item
Good knowledge of German
boolean
C1145677 (UMLS CUI [1])
Handedness
Item
Right-handedness
boolean
C0023114 (UMLS CUI [1])
Control Group
Item
Healthy Volunteers
boolean
C0009932 (UMLS CUI [1])
Item Group
Exclusion Criteria
C0680251 (UMLS CUI-1)
Hypersensitivity to study medication
Item
Known hypersensitivity to the study medication
boolean
C0020517 (UMLS CUI [1,1])
C0304229 (UMLS CUI [1,2])
Contraindications to study medication
Item
All contraindications to the study medication: arrhythmia, hyperthyroidism , glaucoma , pheochromocytoma , congestive heart failure , diabetes mellitus, known liver and kidney dysfunction, vascular disease , angina, haemodynamically significant congenital heart disease , cardiomyopathy , myocardial infarction, channelopathies, arterial hypertension , cerebrovascular diseases , such as cerebral aneurysm , vascular abnormalities , including vasculitis and stroke.
boolean
C1301624 (UMLS CUI [1,1])
C0304229 (UMLS CUI [1,2])
Study Participation Status
Item
Participation in other clinical trials during or within one month prior to this clinical trial
boolean
C2348568 (UMLS CUI [1])
Hazard to Study Protocol
Item
Medical or psychological circumstances that may endanger the proper conduct of the trial
boolean
C0598697 (UMLS CUI [1,1])
C2348563 (UMLS CUI [1,2])
Comorbidity
Item
Existing serious somatic diseases, even if they are not covered by the contraindications according to product information
boolean
C0009488 (UMLS CUI [1])
Mental Disorder
Item
Existing psychiatric disorders and psychiatric disorders in prehistory
boolean
C0004936 (UMLS CUI [1])
Smoking Status
Item
Smoker or ex-smoker for less than 5 years
boolean
C1519386 (UMLS CUI [1])
Caffeine consumption
Item
Regular caffeine consumption > 4 cups per day
boolean
C0948365 (UMLS CUI [1])
Day/night cycles
Item
Subjects with irregular day -night rhythm (eg shift workers )
boolean
C2371703 (UMLS CUI [1])
Unwilling
Item
Unwillingness to the storage and disclosure of pseudonymous data as part of the clinical trial
boolean
C0558080 (UMLS CUI [1])
Accommodation
Item
Accommodation in an institution by court or administrative order (according to AMG § 40 (1) 4 )
boolean
C0595920 (UMLS CUI [1])
MRI contraindications
Item
MRI contraindications ( eg pacemakers , metallic or electronic implants , metallic splinters , tinnitus, surgical clips )
boolean
C0024485 (UMLS CUI [1,1])
C1301624 (UMLS CUI [1,2])
Retour au début de la page 

Contact

Utilisez ce formulaire pour les retours, les questions et les améliorations suggérées.

Les champs marqués d’un * sont obligatoires.

Aide

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial